David Steinhaus - 21 May 2025 Form 4 Insider Report for EBR Systems, Inc. (EBRCZ)

Reporting relationship: Director
Issuer ticker: EBRCZ
Reported as of: 21 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 May 2025, 20:38:27 UTC
Prior SEC filing: 30 Sep 2024
Next SEC filing: 28 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Gary W Doherty, Attorney-in-Fact

Key filing fact

David Steinhaus filed Form 4 for EBR Systems, Inc. (EBRCZ) on 22 May 2025.

Key facts

This page summarizes David Steinhaus's Form 4 filing for EBR Systems, Inc. (EBRCZ).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 22 May 2025, 20:38.

Change

Previous filing in this sequence was filed on 30 Sep 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002037321 Primary reporting owner

Steinhaus David

Relationship: Director
Address: 480 OAKMEAD PARKWAY, SUNNYVALE
Signature: /s/ Gary W Doherty, Attorney-in-Fact
Signature date: 22 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EBRCZ transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +175,781
Change %
Price: $0.000000
Shares after: 175,781
Date: 21 May 2025
Ownership: By the David M. Steinhaus Revocable Trust dated January 20, 2004, as amended and restated
Underlying class: Common Stock
Underlying amount: 175,781
Exercise price: $1.04
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The exercise price was determined and approved by the Board of Directors on March 18, 2025, subject to approval by the Company's stockholders at the 2025 annual meeting of stockholders (including any adjournment or postponement thereof) in accordance with the Listing Rules of the Australian Securities Exchange (ASX).

Footnote F2

The Board of Directors approved the grant on March 18, 2025, subject to approval by the Company's stockholders at the 2025 annual meeting of stockholders (including any adjournment or postponement thereof) in accordance with the Listing Rules of the ASX.

Footnote F3

The option vests in 1/12 equal monthly installments as measured from 5/21/2025, subject to continued employment or service through each such date.